Tomasz M. Wrobel

Jaczewskiego Str. 8b
Lublin, LU 20090, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Synthesis, Molecular Modeling and Assessment of Anticancer Activity of New Potential CYP17A1 Inhibitors.

Synthesis, Molecular Modeling and Assessment of Anticancer Activity of New Potential CYP17A1 Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: April 30, 2026

D2AAK1 derivatives as neuroprotective agents: Synthesis and structural and pharmacological evaluation.

D2AAK1 derivatives as neuroprotective agents: Synthesis and structural and pharmacological evaluation.

Journal: Bioorganic chemistry

Published: January 21, 2026

Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT2A Receptor Ligand.

Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT2A Receptor Ligand.

Journal: Molecules (Basel, Switzerland)

Published: March 26, 2025

Biased signaling via serotonin 5-HT2A receptor: From structural aspects to in vitro and in vivo pharmacology.

Biased signaling via serotonin 5-HT2A receptor: From structural aspects to in vitro and in vivo pharmacology.

Journal: Acta pharmaceutica Sinica. B

Published: March 07, 2025

Pyridine indole hybrids as novel potent CYP17A1 inhibitors.

Pyridine indole hybrids as novel potent CYP17A1 inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: February 14, 2025

Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations.

Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations.

Journal: Journal of chemical information and modeling

Published: September 26, 2024

Bitopic Ligands Support the Presence of a Metastable Binding Site at the β2 Adrenergic Receptor.

Bitopic Ligands Support the Presence of a Metastable Binding Site at the β2 Adrenergic Receptor.

Journal: Journal of medicinal chemistry

Published: July 02, 2024

Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening.

Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening.

Journal: ChemMedChem

Published: January 26, 2024

A comprehensive assessment of palmatine as anticonvulsant agent - In vivo and in silico studies.

A comprehensive assessment of palmatine as anticonvulsant agent - In vivo and in silico studies.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 08, 2023

Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis.

Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis.

Journal: Biomolecules

Published: July 31, 2023

Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment.

Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment.

Journal: Journal of medicinal chemistry

Published: May 16, 2023

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: May 15, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026